Browse studies, page 87
Page 87 of 1,231, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Role of Phosphodiesterase Type 5 Inhibitor on Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms Korean Journal of Andrology, 2011
- Nanomedicine for Benign Prostatic Hyperplasia: Pathological Axes and Translational Evidence International Journal of Nanomedicine, 2026
- Comparing the effect of Alpha blocker (Silodosin) and Phosphodiesterase type 5 inhibitor (Tadalafil) in benign prostate hyperplasia patients with lower urinary tract symptoms: a single centre study International Surgery Journal, 2018
- Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia Cochrane Database of Systematic Reviews, 2017
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia The World Journal of Men s Health, 2018
- Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model Drug Design Development and Therapy, 2018
- Benign Prostatic Hyperplasia: Basic Research & Pathophysiology (MP06) The Journal of Urology, 2019
- Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs Scientific Reports, 2020
- Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions International Journal of Endocrinology, 2014
- Pharmacotherapy and herbal treatment of benign prostatic hyperplasia Frontiers in bioscience, 2014
- Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction The Aging Male, 2018
- Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia International Journal of Molecular Sciences, 2023
- Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH) British Journal of Pharmacology, 2011
- Inhibitors of Sa-Reductase Current pharmaceutical design, 1996
- Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models Journal of Visualized Experiments, 2012
- Experimental evaluation of the influence of isobornylphenols on the development of BPH and the redox potential of prostate cells Experimental and Сlinical Urology, 2021
- MP06-13 inhibition of human prostate stromal cell growth and modulation of cytoskeletal organization by lenalidomide: a NEW treatment option in male luts? Journal of Urology, 2019
- Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants Frontiers in Pharmacology, 2013
- Research progress and clinical evaluation of histotripsy: a narrative review Annals of Translational Medicine, 2022
- Pharmacological substantiation of development of suppositories with indole-3-carbinol and meloxicam for treatment of urologic diseases 2018
- Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome Toxins, 2019
- Cepharanthine may inhibit the proliferation of prostate cells by blocking the EGFR/PI3K/AKT signaling pathway: comprehensive network analysis, molecular docking, and experimental evaluation Frontiers in Pharmacology, 2025
- Potential Efficacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies International Journal of Molecular Sciences, 2026
- The use of PDE5 inhibitors in the treatment of benign prostate hyperplasia and lower urinary tract symptoms: preclinical evidences 2007
- Efficacy of resveratrol in male urogenital tract dysfunctions: an evaluation of pre-clinical data Nutrition research reviews, 2021
- Curcumin inhibits prostate cancer by upregulating miR‐483‐3p and inhibiting UBE2C Journal of biochemical and molecular toxicology, 2024
- Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats BMC Complementary and Alternative Medicine, 2012
- Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats OncoTarget, 2015
- Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia Frontiers in Pharmacology, 2019
- Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator Journal of Pathology, 2021
- Calamagrostis arundinacea Extract Mitigates Testosterone Induced Prostatic Hyperplasia in Rats Pharmaceuticals, 2026
- Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms PLoS ONE, 2018
- Effects of larval extracts from identified Protaetia brevitarsis seulensis against benign prostatic hyperplasia induced by testosterone in rats Food Science & Nutrition, 2021
- MP06-18 phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a RAT model Journal of Urology, 2019
- Exploring the effects and mechanism of peony pollen in treating benign prostatic hyperplasia Heliyon, 2023
- Relative Influence of Ageratum conyzoides L. Plant Extracts on Testosterone Induced Benign Prostatic Hyperplasia in Mice Pharmacognosy Research, 2022
- FERTILITY FACTORS. D-HORMONE IN PREVENTION OF REPRODUCOPATHIES CAUSED BY BENIGN PROSTATIC HYPERPLASIA (Literature review) PROBLEMS OF ENDOCRINE PATHOLOGY, 2023
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model International Journal of Preventive Medicine and Health, 2023
- Chebulinic acid-enriched fraction ameliorates benign prostatic hyperplasia in Sprague-Dawley rats Journal of Reproductive Healthcare and Medicine, 2026
- Peanut Sprout Extracts Cultivated with Fermented Sawdust Medium Inhibits Benign Prostatic Hyperplasia In Vitro and In Vivo The World Journal of Men's Health, 2020
- Inhibitory effects of Pycnogenol®, a pine bark extract, in a rat model of testosterone propionate-induced benign prostatic hyperplasia Laboratory Animal Research, 2018
- Comparison of Different Doses of Petroleum Ether Extracts of Sphaeranthus indicus Linn Against Dutasteride on Testosterone and PSA in Murine Model of Benign Prostatic Hyperplasia 2020
- Effect of rape flower on benign prostatic hyperplasia in rats Brazilian Journal of Pharmaceutical Sciences, 2022
- A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model BMC Complementary and Alternative Medicine, 2019
- Prostatic artery occlusion versus prostatic artery embolization for the management of benign prostatic Hyperplasia: Early results in a canine model British Journal of Radiology, 2022
- Efficacy of Mimosa pudica Methanolic Extract on BPA Induces Benign Prostate Hyperplasia in Albino Mice Uttar Pradesh Journal of Zoology, 2025
- Assessing the Safety and Efficacy of the ClearRing™ Implant for the Treatment of Benign Prostatic Hyperplasia in a Canine Model Current Urology, 2018
- Computer Prediction and Experimental Verification of Guizhi Fuling Pill in the Treatment of Benign Prostatic Hyperplasia Journal of modern pharmacology and pathology, 2024
- Herbal Medicine in the Treatment of Benign Prostate Hyperplasia: A Systematic Review and Meta-Analysis of Animal Studies Acta Veterinaria Eurasia, 2026
- The impact of vitamin D and/or SAW palmetta berry extract on the spermogramm and spermatozoa functioning under the condition of experimental benign prostatic hyperplasia PROBLEMS OF ENDOCRINE PATHOLOGY, 2025
- Hydroxycitric acid inhibits ferroptosis and ameliorates benign prostatic hyperplasia by upregulating the Nrf2/GPX4 pathway World journal of urology, 2025
- Heat-Killed and Live Enterococcus faecalis Attenuates Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia Journal of Microbiology and Biotechnology, 2021
- Suppression of hypothalamic–pituitary–gonadal function by linzagolix in benign prostatic hyperplasia and polycystic ovary syndrome animal models Clinical and Experimental Pharmacology and Physiology, 2023
- Ethanol Extract of Cosmos caudatus Attenuates Oxidative Stress and Inflammation in a Testosterone-Induced Benign Prostatic Hyperplasia Rat Model via Reduction of Malondialdehyde, Interleukin-6, and Tumor-Infiltrating Lymphocytes Activity Tropical Journal of Natural Product Research, 2025
- Phosphodiesterase type 5 inhibitor attenuates chronic ischemia-induced prostatic hyperplasia in a rat model The Prostate, 2019
- Outline of JUA clinical guidelines for benign prostatic hyperplasia International Journal of Urology, 2011
- The Efficacy of L-Arginine for Benign Prostatic Hyperplasia Juntendō Igaku/Juntendo igaku, 2013
- Administration of daily 5MG tadalafil improves NOT only lower urinary tract symptoms BUT also vessel endothelial function in patients with benign prostatic hyperplasia: MP09‐06 The Journal of Urology, 2017
- Comparative Study of Tadalafil And Tamsulosin in Benign Hyperplasia of Prostate For Lower Urinary Tract Symptoms (LUTS) IOSR Journal of Dental and Medical Sciences, 2017
- Benign Prostatic Hyperplasia: from Bench to Clinic Korean journal of urology, 2012
- The Study of Tadalafil and Tamsulosin as Monotherapy for Lower Urinary Tract Symptoms Due to Benign Hyperplasia of Prostate Journal of Evolution of Medical and Dental Sciences, 2019
- A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia The Journal of Urology, 1998
- 049 Administration of Daily 5mg Tadalafil Improves not Only Lower Urinary Tract Symptoms but Also Erectile and Endothelial Dysfunction in Patients With Benign Prostatic Hyperplasia The Journal of Sexual Medicine, 2016
- Urine Mir-21-5P As a Potential Biomarker for Predicting Effectiveness of Tadalafil in Benign Prostatic Hyperplasia Future Science OA, 2018
- Treatment of Benign Prostatic Hyperplasia by Natural Drugs Molecules, 2021
- Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations International Journal of General Medicine, 2014
- The efficacy and safety of 1470 nm diode laser in the treatment of benign prostatic hyperplasia: a prospective, multicenter study Lasers in Medical Science, 2026
- Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients Journal of International Medical Research, 2021
- Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients Frontiers in Surgery, 2022
- Surgical management of benign prostatic hyperplasia in elderly and frail patients: a narrative review Current Opinion in Urology, 2025
- Effect of continuity nursing based on the theory of Knowledge-Attitude-Practice on quality of life, self-efficacy, and treatment compliance in elderly patients with benign prostatic hyperplasia Medicine, 2024
- Effects of a single dose 20 mg tadalafil on resistive index value of prostate zones 2018
- Tadalafil therapy in symptomatic improvement of LUTS due to BPH and associated Erectile Dysfunction 2017
- Modern combination therapy of tadalafil and tamsulosin as a new treatment in men with lower urinary tract symptoms Medycyna Faktów, 2022
- Impacts of medical treatments for lower urinary tract symptoms suggestive to benign prostatic hyperplasia on male sexual functions 2016
- Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction International journal of clinical practice, 2009
- Standardization of the ethanolic extract of Crinum latifolium leaves by two bioactive markers with antiproliferative activity against TGF-β-promoted prostate stromal cells (WPMY-1) BMC complementary medicine and therapies, 2022
- A Study of the Efficacy of the Additional Administration of Tadalafil in Japanese Men with α1-Blocker-Resistant LUTS/BPH Hinyokika kiyo. Acta urologica Japonica, 2016
- Correction of erectile dysfunction in patients with benign prostate hyperplasia using daily administration of tadalafil 5 mg against the background of combined drug therapy Urologiia (Moscow, Russia : 1999), 2013
- Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue Urology, 2008
- Simultaneous screening of 21 potential adulterants in dietary supplements for the treatment of prostate diseases using ultra-performance liquid chromatography and liquid chromatography-electrospray ionization-tandem mass spectrometry Journal of separation science, 2022
- New groups of neuroleptic drugs – phosphodiesterase inhibitors 10A. Narrative review Pharmacotherapy in Psychiatry and Neurology, 2024
- The spinal control of ejaculation revisited: a systematic review and meta-analysis of anejaculation in spinal cord injured patients Human Reproduction Update, 2013
- Effects of Sexual Rehabilitation on Sexual Dysfunction in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis The World Journal of Men s Health, 2023
- The protective role of phosphodiesterase inhibitors in preventing colorectal cancer and advanced colorectal polyps: a systematic review and meta‐analysis Colorectal Disease, 2023
- Are adrenergic α1- antagonists beneficial for the access of retrograde ureteral access sheath or semi-rigid ureteroscope access? A systematic review and meta-analysis Frontiers in Surgery, 2023
- Pumpkin Seed Intervention to Control Diabetes Mellitus: A Systematic Review Open Access Macedonian Journal of Medical Sciences, 2022
- A review of current treatments for chronic prostatitis/chronic pelvic pain syndrome under the UPOINTS system Institutional Repositories DataBase (IRDB), 2023
- Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-Analysis Frontiers in Medicine, 2021
- The role of Silodosin as a new medical expulsive therapy for ureteral stones: a meta-analysis Renal Failure, 2016
- Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis The Aging Male, 2016
- Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis European Urology Focus, 2019
- A systematic review and meta-analysis of the efficacy and safety of mirabegron vs. tamsulosin in alleviating double-J catheter related symptoms Frontiers in Medicine, 2025
- Efficacy of Pregabalin, Solifenacin, or Combination Therapy for Ureteral Stent Related Symptoms: A Systematic Review and Meta-Analysis Siriraj Medical Journal/San Sirirat, 2023
- A Meta-Analysis of Long- Versus Short-Acting Phosphodiesterase 5 Inhibitors: Comparing Combination Use With α-Blockers and α-Blocker Monotherapy for Lower Urinary Tract Symptoms and Erectile Dysfunction International Neurourology Journal, 2015
- 5-α-reductase inhibitors and the risk of suicide and neuropsychiatric symptoms: a meta-analysis of observational studies Frontiers in Urology, 2026
- Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials Frontiers in Pharmacology, 2020
- A narrative review of acupuncture in prostate diseases: perspectives from traditional Chinese medicine, current evidence and future directionsUna revisión narrativa de la acupuntura en enfermedades de la próstata: perspectivas de la medicina tradicional China, evidencia actual y direcciones futuras Revista Internacional de Andrología, 2025
- A meta-analysis of efficacy and safety of PDE5 inhibitors in the treatment of ureteral stent-related symptoms Annals of Palliative Medicine, 2020
- A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate BJUI Compass, 2024
